- The European Medicines Agency (EMA) has greenlit two adapted mRNA COVID-19 vaccines targeting the original strain of COVID-19 as well as the BA.1 Omicron subvariant.
- The UK became the first country to approve a bivalent booster vaccine in mid-August when UK Medicines and Healthcare products Regulatory Agency (MHRA) gave the green light to Moderna’s variant-adapted booster shot targeting the original strain and the Omicron BA.1 subvariant.
- In contrast to the booster vaccines against Omicron subvariant BA.1 approved by the EU and UK, the FDA approved vaccines against the BA.4 and BA.5 variants do not yet have an evaluation based on human data.
EU medicines agency authorises first adapted COVID-19 booster vaccines
